Susquehanna International Group’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
+11,113
| New | +$215K | ﹤0.01% | 5462 |
|
|
2025
Q1 | – | Sell |
-43,735
| Closed | -$1.05M | – | 6403 |
|
|
2024
Q4 | $1.05M | Sell |
43,735
-2,374
| -5% | -$56.8K | ﹤0.01% | 2921 |
|
|
2024
Q3 | $1.29M | Buy |
46,109
+12,565
| +37% | +$351K | ﹤0.01% | 2373 |
|
|
2024
Q2 | $847K | Buy |
33,544
+21,177
| +171% | +$535K | ﹤0.01% | 2776 |
|
|
2024
Q1 | $360K | Sell |
12,367
-35,485
| -74% | -$1.03M | ﹤0.01% | 3944 |
|
|
2023
Q4 | $1.17M | Buy |
+47,852
| New | +$1.17M | ﹤0.01% | 2631 |
|
|
2023
Q3 | – | Sell |
-36,777
| Closed | -$881K | – | 5568 |
|
|
2023
Q2 | $881K | Buy |
36,777
+26,130
| +245% | +$626K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $233K | Sell |
10,647
-25,137
| -70% | -$551K | ﹤0.01% | 4696 |
|
|
2022
Q4 | $894K | Buy |
35,784
+15,501
| +76% | +$387K | ﹤0.01% | 2457 |
|
|
2022
Q3 | $499K | Buy |
+20,283
| New | +$499K | ﹤0.01% | 3544 |
|
|
2022
Q1 | – | Sell |
-9,830
| Closed | -$379K | – | 5741 |
|
|
2021
Q4 | $379K | Buy |
9,830
+1,562
| +19% | +$60.2K | ﹤0.01% | 4187 |
|
|
2021
Q3 | $378K | Sell |
8,268
-5,318
| -39% | -$243K | ﹤0.01% | 4037 |
|
|
2021
Q2 | $678K | Sell |
13,586
-12,103
| -47% | -$604K | ﹤0.01% | 3505 |
|
|
2021
Q1 | $1.32M | Buy |
25,689
+7,933
| +45% | +$408K | ﹤0.01% | 2620 |
|
|
2020
Q4 | $881K | Sell |
17,756
-31,084
| -64% | -$1.54M | ﹤0.01% | 2747 |
|
|
2020
Q3 | $1.9M | Buy |
48,840
+29,457
| +152% | +$1.15M | ﹤0.01% | 1502 |
|
|
2020
Q2 | $837K | Buy |
19,383
+6,099
| +46% | +$263K | ﹤0.01% | 2344 |
|
|
2020
Q1 | $389K | Buy |
13,284
+703
| +6% | +$20.6K | ﹤0.01% | 3159 |
|
|
2019
Q4 | $479K | Buy |
+12,581
| New | +$479K | ﹤0.01% | 2701 |
|
|
2019
Q2 | – | Sell |
-18,990
| Closed | -$541K | – | 4502 |
|
|
2019
Q1 | $541K | Sell |
18,990
-8,568
| -31% | -$244K | ﹤0.01% | 1779 |
|
|
2018
Q4 | $640K | Buy |
27,558
+21,747
| +374% | +$505K | ﹤0.01% | 1901 |
|
|
2018
Q3 | $201K | Buy |
+5,811
| New | +$201K | ﹤0.01% | 2756 |
|
|
2016
Q4 | – | Sell |
-25,119
| Closed | -$569K | – | 4161 |
|
|
2016
Q3 | $569K | Buy |
25,119
+7,300
| +41% | +$165K | ﹤0.01% | 1871 |
|
|
2016
Q2 | $321K | Sell |
17,819
-6,393
| -26% | -$115K | ﹤0.01% | 2459 |
|
|
2016
Q1 | $463K | Sell |
24,212
-8,255
| -25% | -$158K | ﹤0.01% | 2707 |
|
|
2015
Q4 | $943K | Buy |
32,467
+9,523
| +42% | +$277K | ﹤0.01% | 2390 |
|
|
2015
Q3 | $606K | Buy |
+22,944
| New | +$606K | ﹤0.01% | 2935 |
|